These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15059904)

  • 1. Molecular classification and survival prediction in human gliomas based on proteome analysis.
    Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
    Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique four-hub protein cluster associates to glioblastoma progression.
    Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
    PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.
    Schwartz SA; Weil RJ; Thompson RC; Shyr Y; Moore JH; Toms SA; Johnson MD; Caprioli RM
    Cancer Res; 2005 Sep; 65(17):7674-81. PubMed ID: 16140934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification.
    Le Rhun E; Duhamel M; Wisztorski M; Gimeno JP; Zairi F; Escande F; Reyns N; Kobeissy F; Maurage CA; Salzet M; Fournier I
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):875-890. PubMed ID: 27890679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic level changes associated with S3I201 treated U87 glioma cells.
    Jain R; Atak A; Yeola A; Srivastava S
    J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery: a proteomic approach for brain cancer profiling.
    Khalil AA
    Cancer Sci; 2007 Feb; 98(2):201-13. PubMed ID: 17233837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of serum proteome alterations in human glioblastoma multiforme.
    Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
    Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas.
    Iwadate Y; Sakaida T; Saegusa T; Hiwasa T; Takiguchi M; Fujimoto S; Yamaura A
    Int J Oncol; 2005 Apr; 26(4):993-8. PubMed ID: 15753994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12.
    Jain R; Kulkarni P; Dhali S; Rapole S; Srivastava S
    J Proteomics; 2015 Jan; 113():127-42. PubMed ID: 25286751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
    Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
    J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic studies on low- and high-grade human brain astrocytomas.
    Odreman F; Vindigni M; Gonzales ML; Niccolini B; Candiano G; Zanotti B; Skrap M; Pizzolitto S; Stanta G; Vindigni A
    J Proteome Res; 2005; 4(3):698-708. PubMed ID: 15952716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifarious proteomic signatures and regional heterogeneity in glioblastomas.
    Park CK; Jung JH; Park SH; Jung HW; Cho BK
    J Neurooncol; 2009 Aug; 94(1):31-9. PubMed ID: 19219580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.
    Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K
    Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining laser capture microdissection and proteomics techniques.
    Mustafa D; Kros JM; Luider T
    Methods Mol Biol; 2008; 428():159-78. PubMed ID: 18287773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.
    Rajcevic U; Petersen K; Knol JC; Loos M; Bougnaud S; Klychnikov O; Li KW; Pham TV; Wang J; Miletic H; Peng Z; Bjerkvig R; Jimenez CR; Niclou SP
    Mol Cell Proteomics; 2009 Nov; 8(11):2595-612. PubMed ID: 19674965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.
    Thanasupawat T; Glogowska A; Pascoe C; Krishnan SN; Munir M; Begum F; Beiko J; Krcek J; Del Bigio MR; Pitz M; Shen Y; Spicer V; Coombs KM; Wilkins J; Hombach-Klonisch S; Klonisch T
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
    Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
    Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.